CSL Behring (Australia) Pty Ltd, a subsidiary of CSL Limited, is a leading global biotechnology company headquartered in Australia. Established in 1904, CSL Behring has evolved into a key player in the biopharmaceutical industry, focusing on the development and manufacture of innovative therapies for people with serious and rare diseases. With major operational regions across Australia, Europe, and North America, CSL Behring is renowned for its core products, including immunoglobulins, clotting factors, and albumin. These therapies are distinguished by their high quality and efficacy, addressing critical health needs in areas such as immunology and haematology. As a pioneer in the field, CSL Behring has achieved significant milestones, including the introduction of groundbreaking treatments that have transformed patient care. The company’s commitment to research and development solidifies its position as a trusted leader in the biopharmaceutical market.
We don't have data for CSL Behring (Australia) Pty Ltd, but we can show you information about their parent organization instead.
View parent company